Announced
Completed
Synopsis
Evolan Pharma, a pharmaceutical company in Sweden, completed the acquisition of Hydrokortison Trimb, an OTC pharmaceutical product provider, from Karo Pharma, a pharmaceutical company. Financial terms were not disclosed. During the financial year 2018, the total sales of Hydrokortison Trimb amounted to SEK 19.8m.
Principals
Show Details & Financials
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.